This site is currently implementing core features and is not ready for patient use yet.
This site is currently implementing core features and is not ready for patient use yet.
For informational purposes only — not medical advice
Get a free vaccination guide and nearby clinic recommendations — straight to your inbox.
How serious?
Risk of death
Yes
Vaccine available?
Time to symptoms
Countries affected
Active outbreaks
Verify MMR vaccination status. Particularly important for women of childbearing age — rubella during pregnancy can cause severe birth defects. Non-immune women should be vaccinated at least 4 weeks before travel and avoid pregnancy for 4 weeks after vaccination.
Usually mild viral infection causing a distinctive red rash. Critical risk: congenital rubella syndrome (CRS) in unvaccinated pregnant women — causes deafness, blindness, and heart defects in the fetus.
Contagious viral infection known for its distinctive red rash.
Rubella (German measles) is a mild disease in children and adults but causes devastating Congenital Rubella Syndrome when infection occurs in the first trimester of pregnancy. Prevented by the MMR vaccine. WHO declared rubella eliminated from the Americas (2015) and Europe (2023).
Seek urgent care if (mostly relevant to pregnant women and newborns):
Pregnant woman exposed to rubella: immediate serology required; contact obstetric services
Newborn with cataracts, heart murmur, or deafness (CRS screening)
Purpuric rash (bleeding into skin) — thrombocytopenia
Neurological symptoms: headache, confusion, seizures (encephalitis)
Most common signs and symptoms
Postnatal rubella (incubation 14–21 days):
Low-grade fever (38–38.5°C), malaise, and upper respiratory symptoms
Characteristic rash: fine pink/red maculopapular rash beginning on face, spreading to trunk and limbs over 1–3 days; often fades within 3 days
Lymphadenopathy: suboccipital, postauricular, and posterior cervical lymph nodes enlarged and tender — may precede rash by 5–10 days
Arthralgia/arthritis (especially in adult women: ~70%)
Conjunctivitis, Forchheimer spots (petechiae on soft palate) in some cases
~25–50% of infections are subclinical
Congenital rubella syndrome (CRS): Classic triad: cataracts/glaucoma, sensorineural deafness, congenital heart disease (patent ductus arteriosus, pulmonary artery stenosis)
Knowing the symptoms is the first step to a quick response.
Typical disease course (postnatal):
Key feature: Up to 50% of rubella infections are subclinical — serology is needed to confirm diagnosis. The rash is nonspecific and can be confused with many other viral exanthems.
How this disease is identified
Serology: rubella-specific IgM antibody confirms acute infection
IgG seroconversion confirms recent infection
RT-PCR: from nasopharyngeal swab, urine, or blood — most reliable in first week
Prenatal/CRS: fetal blood or amniotic fluid sampling
neonatal serology + viral culture from urine, CSF, throat
All cases must be reported
pregnant contacts require urgent risk assessment
Available treatment methods
No specific antiviral therapy. Management:
Supportive: antipyretics, rest
NSAIDs (ibuprofen) for joint symptoms in adults
Isolation for 7 days after rash onset
Rubella in pregnancy: thorough counseling required regarding CRS risk:
Neonates with CRS require specialist multidisciplinary care (ophthalmology, audiology, cardiology)
Most cases are effectively treated with early diagnosis.
How to protect yourself
MMR vaccine provides 95–99% protection against rubella:
Standard schedule: Dose 1 at 12–15 months; Dose 2 at 4–6 years
Pre-pregnancy screening: all women of childbearing age should verify rubella immunity; vaccinate if seronegative (contraindicated in pregnancy — vaccinate ≥28 days before conception)
Rubella vaccination is contraindicated in pregnancy (live attenuated vaccine)
Immunoglobulin: not routinely recommended but may reduce symptoms in exposed seronegative pregnant women who decline termination
Preparation is the best protection.
Ensure MMR vaccination before travel to any country without rubella elimination status.
Pregnant women: avoid travel to rubella-endemic areas; verify immunity before travel.
Outbreaks reported in parts of Africa, Asia, Middle East, Eastern Europe.
Rubella is highly contagious in non-immune populations; even brief exposure can transmit infection.
Statistics and geographic data
Before widespread vaccination, rubella was endemic globally with peak incidence in children 5–9 years. An estimated 100,000 CRS cases occur annually worldwide (mostly in Africa and Asia). WHO target: global rubella elimination and CRS prevention. Americas (2015) and European Region (2023) achieved elimination status. Outbreaks persist in Africa, Southeast Asia, and in European subpopulations with low vaccine coverage.
Who is most at risk
The most significant risk factor for rubella infection is lack of immunity, whether from absent vaccination or waning immunity. Individuals who have not received rubella-containing vaccine and have no history of natural infection are susceptible. In countries without universal rubella vaccination, seroprevalence studies show susceptibility rates of 10–25% in women of childbearing age.
Living in or traveling to countries where rubella is still endemic increases exposure risk. Crowded living conditions, healthcare settings, and educational institutions facilitate transmission. Healthcare workers, childcare providers, and teachers have occupational risk due to frequent contact with potentially infected individuals.
The most critical risk factor is pregnancy in a non-immune woman. The risk of congenital rubella syndrome varies dramatically by gestational age at the time of maternal infection: approximately 85% during the first 12 weeks, 50% at 13–16 weeks, and decreasing significantly after 20 weeks. This gestational gradient underscores the importance of pre-conception immunity screening and vaccination.
Potential complications
Postnatal complications (uncommon):
Arthritis/arthralgia: very common in adult women (up to 70%)
Thrombocytopenic purpura: 1 in 3,000 cases
Encephalitis: 1 in 6,000 cases
Congenital Rubella Syndrome (CRS) — the critical complication:
Cataracts and/or glaucoma (blindness risk)
Sensorineural hearing loss (most common defect)
Congenital heart disease (PDA, pulmonary stenosis)
Microcephaly, intellectual disability
Diabetes mellitus (late-onset, 20% of survivors)
Thyroid disorders
Progressive rubella panencephalitis (rare, fatal)
Expected outcomes and recovery
Postnatal rubella: Benign. Self-limiting in 3–5 days. Complications rare in children. Adults may have transient arthralgia (especially women, 70%).
Congenital Rubella Syndrome (CRS) — the critical concern:
First-trimester maternal infection: 80–90% risk of CRS.
CRS manifestations: sensorineural deafness (60–75%), congenital heart defects (PDA, pulmonary stenosis), cataracts/glaucoma, intellectual disability, hepatosplenomegaly, thrombocytopenic purpura ("blueberry muffin" rash).
CRS carries significant lifelong morbidity and 10–20% first-year mortality.
Second-trimester infection: risk drops to 10–20%. Third trimester: CRS is rare.
Global: Rubella elimination achieved in the Americas (2015). Vaccination programs have dramatically reduced CRS worldwide.
This disease is vaccine-preventable. Effective protection is available through vaccination.
Talk to a travel health specialist about the recommended schedule before your trip.
Find a vaccination clinic →The content on this page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. If you have health concerns, consult a qualified healthcare professional. Medova is not a medical service provider.
Full terms of useRecent epidemiological data from the World Health Organization Global Health Observatory.
Source: WHO GHO OData ↗
Source: WHO GHO OData ↗
This data is provided for informational purposes. Please consult official WHO sources for the most current information.
View WHO data source →Know which vaccine you need? Great. Not sure? Just tell us your destination — we will figure it out and match you with a clinic. Free, no obligation.